#Interviews Set for Saturday Broadcast
Infrastructure Capital Advisors, LLC and 60 Degrees Pharmaceuticals, Inc. will be highlighted in interviews airing on the RedChip Small Stocks, Big Money™ show this Saturday, April 4, at 7 p.m. Eastern Time on Bloomberg TV. This show provides a platform for emerging companies, reaching an audience in approximately 73 million households across the United States.
#Insights from Infrastructure Capital
Jay Hatfield, the Founder, CEO, and Portfolio Manager of Infrastructure Capital Advisors, is scheduled to discuss his firm's investment philosophy during the broadcast. He emphasizes a disciplined approach to small-cap markets, focusing on independent financial modeling and fundamental analysis. Hatfield aims to uncover pricing inefficiencies in lesser-followed small-cap companies and stresses the importance of identifying profitable businesses while mitigating downside risk through thoughtful valuation frameworks.
#Focus on Health at 60 Degrees Pharmaceuticals
Dr. Geoffrey Dow, CEO of 60 Degrees Pharmaceuticals, will present the company's mission to address vector-borne diseases. He will discuss ARAKODA® (tafenoquine), an FDA-approved treatment for malaria that has been developed in collaboration with the U.S. Army. Dr. Dow looks to expand its applications to include babesiosis, a tick-borne illness with an increasing incidence that currently lacks approved therapies.
#Clinical Trials and Regulatory Status
60 Degrees Pharmaceuticals is actively conducting three clinical trials related to babesiosis, bolstering its commitment to tackling this growing health challenge. The company holds Orphan Drug status for tafenoquine in the babesiosis indication, along with patent exclusivity for malaria through 2035, positioning it uniquely within the pharmaceutical landscape.
#Conclusion
This broadcast presents significant opportunities for both Infrastructure Capital and 60 Degrees Pharmaceuticals to communicate their strategies and innovations to a wide audience. As both companies navigate their respective markets, they aim to connect with potential investors and stakeholders through the insights shared in the upcoming show.
#Key Takeaways
- Jay Hatfield will discuss Infrastructure Capital's small-cap investment strategies on Bloomberg TV.
- Dr. Geoffrey Dow will present 60 Degrees Pharmaceuticals' efforts to treat vector-borne diseases.
- The RedChip Small Stocks, Big Money™ show airs on April 4, reaching an audience across 73 million homes.
- 60 Degrees Pharmaceuticals has ongoing clinical trials for new treatments targeting babesiosis.
- Infrastructure Capital focuses on identifying profitable small-cap companies to mitigate investment risk.
Original source: Read original article